Literature DB >> 16517439

Topiramate, pseudotumor cerebri, weight-loss and glaucoma: an ophthalmologic perspective.

Patrick L Alore1, Walter M Jay, Mícheál P Macken.   

Abstract

Approved for the treatment of epilepsy and migraine prophylaxis, topiramate also acts as a carbonic anhydrase inhibitor implying a potential role in the treatment of pseudotumor cerebri (PTC). Topiramate has a propensity to cause anorexia with consequent weight loss, which alone may be curative in PTC. Prescribers must be aware of several reported cases of acute secondary angle-closure glaucoma reported in patients treated with topiramate.

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16517439     DOI： 10.1080/08820530500509325

Source DB:  PubMed          Journal:  Semin Ophthalmol        ISSN： 0882-0538            Impact factor:   1.975


  6 in total

Review 1.  Current concepts and strategies in the diagnosis and management of idiopathic intracranial hypertension in adults.

Authors:  Jane W Chan
Journal:  J Neurol       Date:  2017-01-31       Impact factor: 4.849

Review 2.  Bilateral acute angle closure glaucoma and myopic shift by topiramate-induced ciliochoroidal effusion: case report and literature review.

Authors:  Yu-Wen Lan; Jui-Wen Hsieh
Journal:  Int Ophthalmol       Date:  2017-10-24       Impact factor: 2.031

3.  High pseudotumor cerebri incidence in tretinoin and arsenic treated acute promyelocytic leukemia and the role of topiramate after acetazolamide failure.

Authors:  Morgan B Smith; Elizabeth A Griffiths; James E Thompson; Eunice S Wang; Meir Wetzler; Craig W Freyer
Journal:  Leuk Res Rep       Date:  2014-07-30

Review 4.  Idiopathic intracranial hypertension: ongoing clinical challenges and future prospects.

Authors:  Parunyou Julayanont; Amputch Karukote; Doungporn Ruthirago; Deepa Panikkath; Ragesh Panikkath
Journal:  J Pain Res       Date:  2016-02-19       Impact factor: 3.133

Review 5.  Preclinical update on regulation of intracranial pressure in relation to idiopathic intracranial hypertension.

Authors:  Sajedeh Eftekhari; Connar Stanley James Westgate; Maria Schmidt Uldall; Rigmor Hoejland Jensen
Journal:  Fluids Barriers CNS       Date:  2019-11-26

6.  Emerging themes in idiopathic intracranial hypertension.

Authors:  Olivia Grech; Susan P Mollan; Benjamin R Wakerley; Zerin Alimajstorovic; Gareth G Lavery; Alexandra J Sinclair
Journal:  J Neurol       Date:  2020-07-22       Impact factor: 4.849
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.